United States: A Prescription For Complying With The TCPA's Proscriptions: Zani V. Rite Aid Headquarters Corp.

David Glynn is a Partner for Holland & Knight's Boston office.

Shannon Salimone is a Partner for Holland & Knight's Tallahassee office.

Anthony Palermo is an Associate for Holland & Knight's Tampa office.

Refill reminder programs implicate an evolving body of both healthcare and consumer protection laws, such as the Health Insurance Portability and Accountability Act (HIPAA) and the Telephone Consumer Protection Act (TCPA), as well as various implementing regulations. The recent case of Zani v. Rite Aid Headquarters Corp. in the Southern District of New York reviewed these laws and provided insight into how pharmacies and health care providers can ensure compliance when instituting a refill reminder program. 14-CV-9701 (AJN), 2017 WL 1383969 (S.D.N.Y. Mar. 30, 2017).

Background

In Zani, the plaintiff received a flu shot at a Rite Aid through a prescription filled by a Rite Aid pharmacist. Zani, 2017 WL 1383969, at *2. Rite Aid later made prerecorded flu shot reminder calls to Rite Aid pharmacy patients, including plaintiff, through a vendor that Rite Aid had designated as a "business associate" under HIPAA. Id. After receiving a reminder call on his cell phone, plaintiff filed a putative class action against Rite Aid on behalf of himself individually and on behalf of all those similarly situated for alleged violations of the TCPA. Id. at *1. Rite Aid moved for summary judgment after a period of discovery, and plaintiff moved for class certification. Id. at *1. In addressing Rite Aid's arguments, the Court examined the statutory and regulatory framework applicable to refill reminder calls under the TCPA, as informed by relevant regulations and pronouncements by the Federal Communications Commission (FCC), the Federal Trade Commission (FTC), and Health and Human Services (HHS).

The TCPA, FCC, and FTC

Among other things, the TCPA prohibits (a) calling cell phones with an automatic telephone dialing system, and (b) calling cell phones or residential phones using an artificial or prerecorded voice, unless the caller has the prior express consent of the called party. Id. at *1, 4; see also 47 U.S.C. § 227(b)(1)(A)-(B). The statute is silent as to the form of express consent—oral, written, or some other kind—required for an otherwise prohibited automated or prerecorded call to avoid the TCPA's proscriptions. Id. at *4. The TCPA authorizes the FCC to prescribe regulations to implement the TCPA, and the FCC has regulated the form of consent required for various calls. Id. Complicating matters of implementation, however, the FTC also regulates telemarketing communications pursuant to the Federal Trade Commission Act. Id. at *5.

The Telemarketing Rule

As the Court noted, pharmacies face a "shifting legal landscape in light of new FCC rules governing automated calls" because of the FCC's efforts to harmonize its TCPA implementing regulations with the FTC's telemarketing rules. Id. at *3, 5. As a result of these efforts, the FCC announced a rule in 2013—referred to in Zani as the "Telemarketing Rule"—that distinguished between automated or prerecorded calls that (a) contain advertising or constitute telemarketing, and (b) those that are, instead, "informational." Id. at *5. The FCC required mere prior express consent for the latter, whereas the FCC required prior express written consent for the former. Id.

Exception for Certain Calls to Residential Lines

When it created the Telemarketing Rule, the FCC also established various exceptions to it that pharmacies should bear in mind when instituting refill reminder programs. Id. First, the FCC excepted automated or prerecorded calls to residential lines from any consent requirement so long as they deliver a "health care" message from or on behalf of a "covered entity" or its "business associate," as such terms are defined in the HIPAA Privacy Rule. Id. The FCC's exemption replicated the FTC's identical exemption of such calls from the FTC's Telemarketing Sales Rule, and the FCC also invoked the same rationale for creating the exemption—"that such calls were already extensively regulated by HIPAA, and that such a narrow exception would be unlikely to tread greatly on consumer's privacy rights." Id.

The Health Care Rule

Second, the FCC created an exception from the Telemarketing Rule's prior express written consent requirement for automated or prerecorded calls to cell phones so long as they deliver "health care" messages from or on behalf of a "covered entity" or its "business associate," as such terms are defined in the HIPAA Privacy Rule. Id. at *6. The Court in Zani referred to this exception to the Telemarketing Rule as the "Health Care Rule." Id.

The FCC's 2015 Exemption for Calls with a "Healthcare Treatment Purpose"

Additionally, in 2015, the FCC exempted a narrower class of health care calls to cell phones from even the prior express consent requirement. Id. To qualify for this exemption, the calls must be of an exigent nature, comply with HIPAA privacy rules, and must be strictly limited to a healthcare treatment purpose; they cannot include any telemarketing, solicitation, advertising, or billing, debt-collection, or other financial content. Id.

Rite Aid's Arguments and the Court's Analysis

In its motion for summary judgment, Rite Aid argued, among other things, that its prerecorded reminder call to plaintiff did not subject it to liability under the TCPA. Id. at *7-8. According to Rite Aid, the call was subject to the Health Care Rule, not the Telemarketing Rule, because it delivered a health care message conveyed by or on behalf of a covered entity or its business associate, and Rite Aid had the prior express consent of plaintiff before calling. Id. at *7. Additionally, Rite Aid argued that its call qualified for the narrower exception for certain health care calls that the FCC created in 2015. Id. The Court in Zani did not reach the latter argument or other alternatives put forth by Rite Aid. Instead, the Court agreed that Rite Aid's call fell subject to the Health Care Rule, and its less demanding consent requirement, rather than the Telemarketing Rule, which requires prior express written consent. Id. Importantly, the Court further concluded that, because the Health Care Rule is an exception to the Telemarketing Rule, evidence that Rite Aid made the calls for marketing purposes was irrelevant. Id. at *8, 12.

At the outset of its analysis, the Court noted the dearth of available case law addressing the text and scope of the FCC's Health Care Rule. Id. at *8. In interpreting the Health Care Rule and analyzing whether Rite Aid's refill reminder call violated the TCPA or whether the Health Care Rule applied to exempt them from the TCPA's proscription, the Court thus relied primarily upon the relevant regulations along with statements by the FCC, HHS, and the FTC interpreting the regulatory text at issue or analogous exemptions. Id.

Conveyed by or on behalf of a "Covered Entity" or its "Business Associate"?

In the first step of its analysis under the Health Care Rule—determining whether the call was conveyed by or on behalf of a "covered entity" or its "business associate"—the Court concluded that, although a separate Rite Aid entity placed the call, this entity was not only a business associate of Rite Aid, a health care provider, but it also acted on Rite Aid's behalf. Id. The Court noted that Rite Aid had designated this separate Rite Aid company and the relevant Rite Aid pharmacy as "affiliated covered entities" under relevant HIPAA regulations, and that the Rite Aid pharmacy had transmitted protected health information (PHI) to its affiliate so that the affiliate could provide services to help Rite Aid make sales—thus meeting the definition of "business associate" set forth in HHS implementing regulations. Id. Further, because the affiliate made the calls to encourage customers to patronize Rite Aid, the Court concluded that the affiliate's calls were made on behalf of Rite Aid. Id. at *9.

Delivered a "Health Care" Message?

In the second step of its analysis under the Health Care Rule—determining whether the call delivered a "health care" message—the Court looked to HHS regulations implementing HIPAA, as well as pronouncements by the FCC and FTC and the limited case law available. Id. at *9-10. Based upon the regulatory text and other guidance, the Court held that three factors are material to whether a call conveys a health care message:

  • whether the call concerns a "health-related product or service," as defined by the FTC;1
  • whether the call is placed by or on behalf of a health care provider to a patient with whom the provider has an established health care treatment relationship; and
  • whether the call concerns the individual health care needs of the patient-recipient such that a nexus exists between the subject matter of the call and the established health care needs of the called party. Id. at *11.

The Court refrained from deciding whether each factor must exist for a call to convey a health care message—or whether meeting one or two factors would be sufficient—because the Court found that the undisputed facts demonstrated that Rite Aid's flu reminder call satisfied each of the three factors. Id.
The Court determined that Rite Aid's call met each of the factors material to determining whether a call conveys a health care message because:

  • Rite Aid's calls concerned the availability of a prescription medication administered at its pharmacies, and the administration of medicine pursuant to a prescription constitutes a health-related product under even the most narrow reading of the Health Care Rule, as interpreted through HHS regulations implementing HIPAA, FTC guidance, and the relevant FCC Order. Id.
  • The calls were made only to patients of Rite Aid pharmacies who had previously filled prescriptions at those pharmacies. The calls were not directed to the general public, but instead, were made within the context of an established health care relationship. Id.
  • The calls alerted the patient-recipients to the availability of a medication treating the precise medical issue for which they previously sought care. Id. Thus, the calls concerned an established medical need of the individual recipients. Id. at *12.

In rejecting plaintiff's arguments that Rite Aid's calls did not convey a health care message, the Court reached several notable conclusions. First, although "health care" must relate to the "health of an individual," the Court rejected the notion that health care must be "individualized" pursuant to HHS guidance. Id. (emphasis in original). While HHS previously explained that certain generic manufacturers, who have no relationship with any individual patient, would not be "providing 'health care'" so as to come under the HIPAA regulatory framework, HHS did not go so far as to say that "the same health care message or product could not be delivered to numerous patients and still qualify as health care." Id.

Second, the Court rebuffed plaintiff's argument that the call's lack of individualization meant that it failed to qualify as a health care message because it did not contain PHI, as defined by HIPAA regulations. Id. at *13. The Court explained that the FCC had addressed the inclusion of personalized information in automated, prerecorded health care messages sent to patients and that not only had the FCC not required such information in these messages, but the FCC cautioned that such information was unnecessary and discouraged. Id. Even assuming a call must be subject to HIPAA to qualify for the Health Care Rule—which the text of the rule does not require—the Court determined that the calls could fall under HIPAA's regulation even without containing PHI because HIPAA may govern the sharing of the patient's contact information that produced and allowed for the calls. Id.

Next, in distinguishing a recent FCC decision relied upon by the plaintiff, the Court noted that in the situation that the FCC had confronted, the communications at issue were not sent only to patients of the petitioner who had previously received prescriptions for flu vaccines, but they were instead sent to "various corporations" to alert them to the availability of flu shots. Id. at *14. In holding that, in contrast, Rite Aid's calls conveyed a health care message, the Court explained that it was not relying solely upon the fact that the calls concerned prescription medication availability, but that the calls were also made exclusively to Rite Aid patients concerning a prescription for medicine for a specific health problem for which they had previously sought care. Id. 2

Finally, the Court rejected plaintiff's argument that the calls would be subject to the Telemarketing Rule, and its elevated requirement of prior express written consent, because Rite Aid made the calls for a marketing purpose. Id. at *15. The Court explained that the plain text of the regulation, as well as its structure and purpose, compels the conclusion that the Health Care Rule is an exception to the Telemarketing Rule; therefore, "a call that would otherwise be telemarketing or advertising is subject to the Health Care Rule, and its lower consent requirement, if the call conveys a health care message." Id. (emphasis in original). The Court found it persuasive that the only other district court to address this issue had reached the same conclusion under the same rationale. Id. at *15. The Court also determined that the FCC's 2012 and 2015 Orders did not require a contrary conclusion, and that the FTC's statements regarding its textually identical exemption to the FTC's telemarketing rules—which the FCC patterned its exemption after—corroborated the Court's ruling that the FCC's Health Care Rule is an exemption to the Telemarketing Rule. Id. at *16-17. Thus, even if Rite Aid's purpose in calling was to advertise its flu shots—because Rite Aid conveyed a health care message and the call was therefore exempted from the Telemarketing Rule—such purpose was immaterial to the Court's analysis. Id. at *17.

Conclusion

Because Rite Aid's call delivered a health care message and was conveyed by a business associate on Rite Aid's behalf, the call was subject to the Health Care Rule and its reduced consent requirement, rather than the Telemarketing Rule's prior express written consent requirement. Id. at *18. Prior to calling, Rite Aid had secured plaintiff's prior express consent to call when the plaintiff provided his cell phone number to Rite Aid. Id. at *3, 18. As a result, the Court granted Rite Aid's motion for summary judgment, finding that no reasonable jury could find Rite Aid liable for violating the TCPA, and the Court denied plaintiff's motion for class certification as moot. Id. In holding that Rite Aid did not violate the TCPA, the Court not only cleared Rite Aid of liability, the Court also illuminated the regulatory morass of consumer protection and healthcare laws governing automated calls—providing other pharmacies and providers a prescription for preventive care that could reduce the risk of deleterious side effects from implementing a refill reminder program.

Key takeaways:

  • In order to be exempt from any consent requirement for calls to residential lines and to qualify for the Health Care Rule's less demanding consent requirements for calls to cell phones, automated or prerecorded calls must deliver a "health care" message made by, or on behalf of, a "covered entity" or its "business associate," as such terms are defined in the HIPAA Privacy Rule. Id. at *5-6.
  • Because the Health Care Rule is an exception to the Telemarketing Rule, the Health Care Rule may apply and exempt a cell phone call from the TCPA's prior express written consent requirement even where a message contains advertising. Id. at *14. If a call conveys a health care message, regardless of whether it also has the characteristics of telemarketing or advertising, it requires only prior express consent, rather than prior express written consent. Id. at *15.
  • To qualify for the Health Care Rule's reduced consent requirement for calls to cell phones, a pharmacy should either place the calls itself or utilize a "business associate" and, whether placed by the pharmacy or business associate, the calls should clear note that they are being made on the pharmacy's behalf. Id. at *8-9.
  • In order to ensure that a call's content falls within the parameters of a "health care" message, pharmacies should make clear that their call relates to a prescription drug that they provide. Id. at *9-10. Such drugs must be prescribed by a doctor or other health care provider as part of a plan of treatment. Id. at *10. Calls should omit mention of products or services not prescribed by a doctor or health care provider, such as vitamins or minerals. Id.
  •  Further, although their calls need not be individualized, pharmacies should only call patients with whom they already have an established relationship, and the calls should relate to prescription medications that the patients have previously received. See id. at *12-14.

 Footnotes

1. The FTC defines this category to include the administration of medicine prescribed by a doctor or health care provider. Id. at *11. It does not include any product that may benefit a consumer's health, however, and thus excludes products or services "not prescribed by a doctor or other health care provider as part of a plan of treatment," such as vitamins or minerals. Id. at *10 (emphasis added).

2. Because the Court did not indicate that either factor was sufficient to exempt Rite Aid's call from liability, as noted in the key takeaways section below, pharmacies should only call patients with whom they already have an established relationship, and the calls should relate to prescription medications that the patients previously received in order to ensure that the calls do not run afoul of the TCPA and subject the pharmacies to potential class actions thereunder.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

Authors
 
In association with
Related Video
Up-coming Events Search
Tools
Print
Font Size:
Translation
Channels
Mondaq on Twitter
 
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
 
Email Address
Company Name
Password
Confirm Password
Position
Mondaq Topics -- Select your Interests
 Accounting
 Anti-trust
 Commercial
 Compliance
 Consumer
 Criminal
 Employment
 Energy
 Environment
 Family
 Finance
 Government
 Healthcare
 Immigration
 Insolvency
 Insurance
 International
 IP
 Law Performance
 Law Practice
 Litigation
 Media & IT
 Privacy
 Real Estate
 Strategy
 Tax
 Technology
 Transport
 Wealth Mgt
Regions
Africa
Asia
Asia Pacific
Australasia
Canada
Caribbean
Europe
European Union
Latin America
Middle East
U.K.
United States
Worldwide Updates
Check to state you have read and
agree to our Terms and Conditions

Terms & Conditions and Privacy Statement

Mondaq.com (the Website) is owned and managed by Mondaq Ltd and as a user you are granted a non-exclusive, revocable license to access the Website under its terms and conditions of use. Your use of the Website constitutes your agreement to the following terms and conditions of use. Mondaq Ltd may terminate your use of the Website if you are in breach of these terms and conditions or if Mondaq Ltd decides to terminate your license of use for whatever reason.

Use of www.mondaq.com

You may use the Website but are required to register as a user if you wish to read the full text of the content and articles available (the Content). You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these terms & conditions or with the prior written consent of Mondaq Ltd. You may not use electronic or other means to extract details or information about Mondaq.com’s content, users or contributors in order to offer them any services or products which compete directly or indirectly with Mondaq Ltd’s services and products.

Disclaimer

Mondaq Ltd and/or its respective suppliers make no representations about the suitability of the information contained in the documents and related graphics published on this server for any purpose. All such documents and related graphics are provided "as is" without warranty of any kind. Mondaq Ltd and/or its respective suppliers hereby disclaim all warranties and conditions with regard to this information, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. In no event shall Mondaq Ltd and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use or performance of information available from this server.

The documents and related graphics published on this server could include technical inaccuracies or typographical errors. Changes are periodically added to the information herein. Mondaq Ltd and/or its respective suppliers may make improvements and/or changes in the product(s) and/or the program(s) described herein at any time.

Registration

Mondaq Ltd requires you to register and provide information that personally identifies you, including what sort of information you are interested in, for three primary purposes:

  • To allow you to personalize the Mondaq websites you are visiting.
  • To enable features such as password reminder, newsletter alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our information providers who provide information free for your use.

Mondaq (and its affiliate sites) do not sell or provide your details to third parties other than information providers. The reason we provide our information providers with this information is so that they can measure the response their articles are receiving and provide you with information about their products and services.

If you do not want us to provide your name and email address you may opt out by clicking here .

If you do not wish to receive any future announcements of products and services offered by Mondaq by clicking here .

Information Collection and Use

We require site users to register with Mondaq (and its affiliate sites) to view the free information on the site. We also collect information from our users at several different points on the websites: this is so that we can customise the sites according to individual usage, provide 'session-aware' functionality, and ensure that content is acquired and developed appropriately. This gives us an overall picture of our user profiles, which in turn shows to our Editorial Contributors the type of person they are reaching by posting articles on Mondaq (and its affiliate sites) – meaning more free content for registered users.

We are only able to provide the material on the Mondaq (and its affiliate sites) site free to site visitors because we can pass on information about the pages that users are viewing and the personal information users provide to us (e.g. email addresses) to reputable contributing firms such as law firms who author those pages. We do not sell or rent information to anyone else other than the authors of those pages, who may change from time to time. Should you wish us not to disclose your details to any of these parties, please tick the box above or tick the box marked "Opt out of Registration Information Disclosure" on the Your Profile page. We and our author organisations may only contact you via email or other means if you allow us to do so. Users can opt out of contact when they register on the site, or send an email to unsubscribe@mondaq.com with “no disclosure” in the subject heading

Mondaq News Alerts

In order to receive Mondaq News Alerts, users have to complete a separate registration form. This is a personalised service where users choose regions and topics of interest and we send it only to those users who have requested it. Users can stop receiving these Alerts by going to the Mondaq News Alerts page and deselecting all interest areas. In the same way users can amend their personal preferences to add or remove subject areas.

Cookies

A cookie is a small text file written to a user’s hard drive that contains an identifying user number. The cookies do not contain any personal information about users. We use the cookie so users do not have to log in every time they use the service and the cookie will automatically expire if you do not visit the Mondaq website (or its affiliate sites) for 12 months. We also use the cookie to personalise a user's experience of the site (for example to show information specific to a user's region). As the Mondaq sites are fully personalised and cookies are essential to its core technology the site will function unpredictably with browsers that do not support cookies - or where cookies are disabled (in these circumstances we advise you to attempt to locate the information you require elsewhere on the web). However if you are concerned about the presence of a Mondaq cookie on your machine you can also choose to expire the cookie immediately (remove it) by selecting the 'Log Off' menu option as the last thing you do when you use the site.

Some of our business partners may use cookies on our site (for example, advertisers). However, we have no access to or control over these cookies and we are not aware of any at present that do so.

Log Files

We use IP addresses to analyse trends, administer the site, track movement, and gather broad demographic information for aggregate use. IP addresses are not linked to personally identifiable information.

Links

This web site contains links to other sites. Please be aware that Mondaq (or its affiliate sites) are not responsible for the privacy practices of such other sites. We encourage our users to be aware when they leave our site and to read the privacy statements of these third party sites. This privacy statement applies solely to information collected by this Web site.

Surveys & Contests

From time-to-time our site requests information from users via surveys or contests. Participation in these surveys or contests is completely voluntary and the user therefore has a choice whether or not to disclose any information requested. Information requested may include contact information (such as name and delivery address), and demographic information (such as postcode, age level). Contact information will be used to notify the winners and award prizes. Survey information will be used for purposes of monitoring or improving the functionality of the site.

Mail-A-Friend

If a user elects to use our referral service for informing a friend about our site, we ask them for the friend’s name and email address. Mondaq stores this information and may contact the friend to invite them to register with Mondaq, but they will not be contacted more than once. The friend may contact Mondaq to request the removal of this information from our database.

Security

This website takes every reasonable precaution to protect our users’ information. When users submit sensitive information via the website, your information is protected using firewalls and other security technology. If you have any questions about the security at our website, you can send an email to webmaster@mondaq.com.

Correcting/Updating Personal Information

If a user’s personally identifiable information changes (such as postcode), or if a user no longer desires our service, we will endeavour to provide a way to correct, update or remove that user’s personal data provided to us. This can usually be done at the “Your Profile” page or by sending an email to EditorialAdvisor@mondaq.com.

Notification of Changes

If we decide to change our Terms & Conditions or Privacy Policy, we will post those changes on our site so our users are always aware of what information we collect, how we use it, and under what circumstances, if any, we disclose it. If at any point we decide to use personally identifiable information in a manner different from that stated at the time it was collected, we will notify users by way of an email. Users will have a choice as to whether or not we use their information in this different manner. We will use information in accordance with the privacy policy under which the information was collected.

How to contact Mondaq

You can contact us with comments or queries at enquiries@mondaq.com.

If for some reason you believe Mondaq Ltd. has not adhered to these principles, please notify us by e-mail at problems@mondaq.com and we will use commercially reasonable efforts to determine and correct the problem promptly.